Literature DB >> 6969345

Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature.

B F Haynes, M I Kaiser-Kupfer, P Mason, A S Fauci.   

Abstract

Typical Cogan syndrome (CS) is a disease of young adults consisting of flares of interstitial keratitis (IK) and sudden onset of Ménière-like attacks. The prognosis of typical CS is excellent with life-threatening aortic insufficiency (AI) developing in only 10% of reported cases. Serious systemic necrotizing vasculitis (SNV) rarely, if ever, complicates typical CS. Atypical S (vestibuloauditory dysfunction with types of inflammatory eye disease other than IK) frequently overlaps other defined rheumatologic syndromes, is associated with vasculitis in 21% of cases, and carries a less favorable prognosis than typical CS. Topical ocular corticosteroids can usually control IK, and a short trial of systemic corticosteroids is warranted as soon as possible after the onset of hearing loss. SNV should be treated initially with prednisone and may also require the administration of cytotoxic agents, while aortitis and AI can be controlled with the administration of prednisone and surgical replacement of the aortic valve.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969345

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  59 in total

1.  The cerebral angiographic findings in Cogan syndrome.

Authors:  M S Albayram; R Wityk; D M Yousem; S J Zinreich
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

2.  Cogan's syndrome: an oculo-audiovestibular disease.

Authors:  J R García Berrocal; J A Vargas; M Vaquero; S Ramón y Cajal; R A Ramírez-Camacho
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

Review 3.  Aneurysmatic disease in patients with Takayasu disease: a case review.

Authors:  S Perrotta; G Rådberg; A Perrotta; S Lentini
Journal:  Herz       Date:  2011-11-11       Impact factor: 1.443

4.  Cogan's syndrome complicated by lacunar brain infarcts.

Authors:  A Karni; M Sadeh; I Blatt; Y Goldhammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

Review 5.  A shifty diagnosis: Cogan's syndrome. A case report and review of the literature.

Authors:  G Migliori; E Battisti; M Pari; N Vitelli; C Cingolani
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-04       Impact factor: 2.124

6.  Treatment of Cogan's syndrome with FK 506: a case report.

Authors:  M I Roat; R A Thoft; A W Thomson; A Jain; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  A novel therapeutic option in Cogan diseases? TNF-alpha blockers.

Authors:  M Fricker; A Baumann; F Wermelinger; P M Villiger; A Helbling
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

8.  Low-dose oral methotrexate for the management of childhood Cogan's syndrome: a case report.

Authors:  Yuzaburo Inoue; Takuya Tomemori; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Naoki Shimojo; Yoichi Kohno
Journal:  Clin Rheumatol       Date:  2007-07-05       Impact factor: 2.980

Review 9.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

Review 10.  Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms.

Authors:  Francesca Yoshie Russo; Massimo Ralli; Daniele De Seta; Patrizia Mancini; Alessandro Lambiase; Marco Artico; Marco de Vincentiis; Antonio Greco
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.